Aio-studien-ggmbh

This study tested a combination of three targeted drugs (encorafenib, binimetinib, and cetuximab) given for 8 weeks before surgery to people with a specific genetic type of localized colon cancer (BRAF V600E mutated). The goal was to see if this 'neoadjuvant' approach could shrin…

This study tested if a new combination of chemotherapy drugs (nal-IRI with 5-FU) could better control advanced bile duct cancer compared to a standard treatment. It involved 93 adults whose cancer could not be removed by surgery. The main goal was to see if the new combination co…

This study tested whether adding the immunotherapy drug atezolizumab to standard chemotherapy (carboplatin and etoposide) is safe and effective for people with advanced small cell lung cancer who are in poor overall health. It involved 70 participants who were too frail for most …